1259528-78-3

Basic information

• Product Name: C₃₆H₄₀N₄O₅
• Synonyms: C₃₆H₄₀N₄O₅
• CAS NO: 1259528-78-3
• Molecular Weight: 608.737
• Mol File: 1259528-78-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₃₆H₄₀N₄O₅(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₆H₄₀N₄O₅(1259528-78-3)
• EPA Substance Registry System: C₃₆H₄₀N₄O₅(1259528-78-3)

Safety Data

• Hazardous Substances Data: 1259528-78-3(Hazardous Substances Data)

Upstream product

• 581-96-4 2-naphthylacetic acid 
• 92122-45-7 Fmoc-D-Lys(BOC)-OH 

Downstream Products

• 1259528-72-7 C₅₀H₄₈N₆O₁₀ 

Relevant articles and documents

Design and synthesis of nanofibers of self-assembled de novo glycoconjugates towards mucosal lining restoration and anti-inflammatory drug delivery

The medical practice for IBD is solely based on anti-inflammatory drugs, but the outcome is far from ideal. Our long-term research goal is to seek a better clinical outcome by combining the anti-inflammatory therapy with physical mucus layer restoration. As the first step towards that objective, we choose to develop self-assembled hydrogels of de novo glycoconjugates that consist of anti-inflammatory drugs and glycopeptides. By covalently linking peptides (e.g., nap-phe-phe-lys), saccharides (e.g., glucosamine), and an anti-inflammatory drug (i.e., olsalazine), we have demonstrated that the obtained molecules self-assemble in water to form hydrogels composed of 3D networks of the nanofibers under acidic conditions. We also confirmed that the resulting glycoconjugates are cell compatible. However, the preliminary assessment of the efficacy of the hydrogels on the murine model is inconclusive, which warrants further investigation and molecular engineering.